Cadila Pharma celebrated World Mental Health Day on October 10, 2019, as a part of its care with compassion campaign, raising awareness about how people suffering from mental disorders can take the extreme step of suicide and how to prevent it, which was the theme for this year.
India contributes significantly to the global suicide rates. The nation accounts for over a third of the world’s annual female suicides and nearly a fourth of male suicides. These numbers are worrisome because it talks about the insensitivity towards mental disorders.
Suicides can be directly linked to mental disorders where depression acts as a huge trigger. To tackle this, Cadila Pharmaceuticals’ CNS division decided to raise awareness on this year’s World Mental Health Day.
Healthcare professionals from across India educated the patients about the triggers that can lead to suicide and how to identify and overcome them. Cadila also raised awareness for the patients by talking about the symptoms of mental disorders and how to help their friends overcome it.
In his message, Dr Samyak Tiwari, a leading psychiatrist from Lucknow said, “There is no situation that cannot be dealt with in due time. People should have faith and gather strength to fight it. The situation will pass but a lost life can never be recovered.”
The campaign was a success as these messages reached a variety of audience and people talked about the taboo topic of suicide.
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world. Its innovation-led drug discovery processes ensure the health and well-being of people around the world. Being a care-focused, research-driven company, we are committed to complying with the highest ethical standard in clinical research and medical practice.
